1. Mexico Stocks

  2. •

    Consumer Defensive

  3. •

    Household & Personal Products
Kimberly-Clark de México, S. A. B. de C. V.

Kimberly-Clark de México, S. A. B. de C. V.

KCDMY
Kimberly-Clark de México, S. A. B. de C. V.US flagOther OTC
11.15
USD
-0.02
- -
6.70BMarket Cap
Kimberly-Clark de México, S. A. B. de C. V.
KCDMY
(Other OTC)

Recent

price

11.15

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
40.84
42.12
46.48
47.29
46.74
52
57.7
61.21
66.5
70.51
75.7
76.21
83.01
86.67
89.28
91.49
70.77
Revenue per Share
6.58
5.61
6.57
7.36
5.69
6.99
7.76
6.54
6.85
8.36
9.86
7.3
8.03
11.4
12.76
12.53
10.15
Basic EPS, GAAP
6.23
4.35
9.38
9.35
6.13
9.66
5.26
4.78
8.37
14.73
15.43
7.55
10.04
18.02
13.2
13.2
9.68
Free Cash Flow per Basic Share
5.39
5.68
6.01
6.61
7.03
3.7
7.61
7.9
- -
- -
8
8.61
8.2
8.1
9.32
10.26
5.18
Dividend per Share
14.96
13.85
13.9
13.85
11.07
10.52
10.22
8.68
7.8
8.45
10
8.31
8.14
11.45
12.6
12.66
4.9
Book Value per Share
14.7
13.53
11.34
11.33
8.62
8.41
5.67
4.4
3.78
3.24
4.34
4.64
3.74
7.11
8.13
8.13
0.44
Tangible Book Value per Share
641
635
630
628
623
619
618
617
617
617
617
615
615
615
614
605
600
Basic Weighted Avg Shares
26,197
26,732
29,289
29,678
29,107
32,206
35,660
37,766
41,026
43,500
46,703
46,894
51,055
53,307
54,782
55,371
42,459
Sales/Revenue/Turnover
26.27
21.63
22.63
24.29
20.17
22.16
22.49
18.49
18.3
20.68
22.56
17.81
17.51
22.38
23.45
21.84
22.59
Operating Margin (%)
1,190
1,344
1,498
1,517
1,616
1,665
1,601
1,600
1,562
1,946
1,953
1,935
1,963
1,985
2,048
2,017
1,514
Depreciation Expense
4,223
3,559
4,140
4,619
3,544
4,333
4,794
4,037
4,227
5,156
6,086
4,494
4,936
7,013
7,830
7,581
6,088
Net Income, GAAP
28.55
29.41
30.73
30.11
30.15
30.93
31.04
29.83
29.73
31.01
31.47
32.53
31.92
32.49
32.14
28.76
27.53
Effective Tax Rate (%)
16.12
13.31
14.14
15.56
12.18
13.45
13.44
10.69
10.3
11.85
13.03
9.58
9.67
13.16
14.29
13.69
14.34
Profit Margin (%)
7,592
5,991
3,627
3,424
4,158
6,702
4,949
4,177
5,573
3,813
13,262
8,292
13,934
12,486
8,801
7,070
12,180
Working Capital
11,229
11,222
9,979
10,178
13,087
17,238
20,763
21,630
24,006
22,063
28,726
26,348
31,913
24,979
22,559
19,614
29,586
LT Debt
9,527
8,679
8,626
8,587
6,934
6,738
7,086
6,147
5,603
5,173
5,693
5,724
5,027
6,921
7,407
7,236
2,525
Total Equity
24.01
20.28
23.29
24.87
19.8
21.97
21.54
17.61
17.95
20.42
20.77
15.21
16.42
21.08
24.05
26.88
23.65
Return on Invested Capital (%)
22.44
20.18
23.51
24.98
19.59
22.05
21.82
18.23
18.86
21.63
22.03
16.29
17.67
23.56
26.28
28.04
24.08
Return on Capital (%)
46.3
38.71
47.2
52.95
45.48
64.61
74.68
69.15
83.12
102.83
106.94
79.67
97.53
116.42
106.02
98.52
198.77
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
- -
1,745
1,722
LT Borrowings
- -
18,952
28,965
LT Finance Leases
- -
662
621
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
- -
3,001
3,001
Market Capitalization
117,466
116,657
126,954

Working Capital

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
- -
22,640
34,416
Cash, Cash Equivalents & STI
- -
7,797
20,361
Accounts Receivable, Net
- -
8,256
9,038
Inventories
- -
4,309
4,187
Total Current Liabilities
- -
15,570
22,235
Payables & Accruals
- -
- -
- -
ST Debt
- -
1,745
1,722
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
1.62%
6.15%
-2.3%
Free Cash Flow
13.38%
6.57%
-1.37%
Net Income, GAAP
7.38%
6.85%
-3.18%
Sales/Revenue/Turnover
5.62%
3.51%
1.08%
Total Cash Common Dividend
- -
4.93%
8.55%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
13,790
14,068
13,155
13,771
54,782
2025
13,833
14,070
- -
14,058
55,371
2026
14,331
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
3.4
3.45
2.95
2.95
12.76
2025
3
3.1
- -
3.65
12.53
2026
3.4
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
2.31
4.71
9.32
2025
- -
- -
- -
5.16
10.26
2026
- -
- -
- -
- -
- -
Similar Companies
Hankook Cosmetics Manufacturing Co., Ltd (003350.KS)
Procter & Gamble Hygiene and Health Care Limited (PGHH.NS)
AMOREPACIFIC Group (002795.KS)
Bemax Inc. (BMXC)
Société BIC S.A. (BB.PA)
Chengdu Rainbow Appliance (Group) Shares Co., Ltd. (003023.SZ)
Business
Kimberly-Clark de México, S. A. B. de C. V. (KCDMY) manufactures, distributes and sells a broad range of disposable personal care, hygiene and cleaning products in Mexico and for export markets. The company operates through three main segments: Consumer Products, which includes diapers (Huggies, KleenBebé), training pants (Pull-Ups), feminine care pads (Kotex, Pétalo, Vogue), incontinence products (Depend), bathroom and facial tissues (Kleenex, Cottonelle, Suavel, Sanitas), napkins, kitchen towels, wet wipes, baby care items (shampoos, lotions, feeding products, Evenflo), bar soaps (Kleenex, Escudo Antibacterial) and other home care products such as antibacterial gels and food wraps; Professional and Healthcare, which supplies personal care products to commercial clients including hotels, restaurants, offices and hospitals; and Export, focused on international sales primarily to the United States, Central and South America and Asia. Founded in 1959 through the acquisition of Compañía Papelera La Aurora (established 1925) by Kimberly-Clark Corporation and headquartered in Mexico City, the company employs approximately 9,465 people and maintains manufacturing facilities including paper mills in Naucalpan and Orizaba, Veracruz. It serves consumer, professional and export markets with a portfolio of leading brands including Huggies, KleenBebé, Kleenex, Kotex, Pétalo, Cottonelle, Depend, Evenflo, Escudo Antibacterial, Kimlark and Sanitas. In recent developments, Kimberly-Clark de México sustains a key strategic relationship with parent Kimberly-Clark Corporation for export growth, including finished personal care products to the US, while its Mexican operations remain outside the parent's 2025 announced US$3.4 billion joint venture with Suzano S.A. for international tissue and professional products (expected to close mid-2026). The company invested 2,500 million pesos in capital expenditures during 2024 for technological improvements, cost reductions, efficiency gains and capacity expansion, planning US$120 million more in 2025 alongside entry into new categories such as pet food and shampoos, and expansion into underpenetrated market segments. It reported Q2 2025 sales of 14.1 billion pesos (flat year-over-year, with 3.3% price/mix growth offsetting volume declines and 24.5% export surge), alongside ongoing cost-saving initiatives yielding approximately 500 million pesos in savings, robust cash flow supporting share buybacks (400 million pesos remaining for 2025) and a focus on innovations amid softer domestic consumption.

Company News

APIChat